EUVIMEDEUVIMED entdecken
Open Access

Long non-coding RNA LOC101926915-encoded micropeptide carboplatin-induced upregulation factor confers carboplatin resistance in ovarian cancer

Man Li, YingRu Xu, ZhiBiao Mai, Liangliang Ren, Xuexin Yu, SuWen Chen, ZunFu Ke, Ruyuan Yu iD

Cytojournal · 21.07.2026 · 23 · 44

DOI: 10.25259/cytojournal_99_2025 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cytojournal, online erschienen am 21.07.2026. Verfasst von Man Li und 7 weiteren Autor:innen. Beteiligte Einrichtung: Precision Medicine Institute, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, China. Die Arbeit nennt 39 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

While carboplatin remains a cornerstone chemotherapeutic agent for ovarian carcinoma, the emergence of resistance constitutes a major contributor to therapeutic failure and compromised clinical outcomes. This study elucidates molecular mechanisms driving carboplatin resistance and identifies novel therapeutic targets for carboplatin-refractory malignancies through characterization of a long non-coding RNA (lncRNA)-encoded micropeptide. Material and Methods: Ribosome profiling analysis delineated translational alterations induced by carboplatin in ovarian cancer models. Mechanistic validation was achieved through the integration of gain- and loss-of-function methodologies, nuclear localization assays, and quantitative assessment of deoxyribonucleic acid (DNA) damage through enumeration of gamma-H2AX (phosphorylated histone H2AX at serine 139) foci, supplemented by alkaline comet analysis. The therapeutic significance was corroborated using subcutaneous xenograft models derived from patient-derived ovarian cancer cells.

Results

The micropeptide carboplatin-induced upregulation factor (CARUF), derived from lncRNA LOC101926915, was markedly upregulated in response to carboplatin treatment, with ribosome profiling showing significant enrichment of ribosome-associated LOC101926915 transcripts (adjusted P < 0.01 and log2FC >1). In clinical specimens, elevated CARUF expression was positively correlated with platinum resistance (r = 0.425, P < 0.001). Functional analyses showed that CARUF overexpression promoted DNA damage repair ( P < 0.001) and enhanced carboplatin resistance both in vitro and in vivo ( P < 0.001). In contrast, CARUF inhibition impaired DNA damage repair ( P < 0.001) and restored carboplatin sensitivity ( P < 0.001), resulting in reduced cell viability in vitro ( P < 0.001) and suppressed tumor growth in vivo ( P < 0.001). Mechanistically, carboplatin-induced DNA lesions activated ataxia-telangiectasia mutated and Rad3-related (ATR) kinase, which phosphorylated CARUF, facilitated its localization to DNA lesion sites, and enhanced DNA repair capacity.

Conclusion

Our findings identify CARUF as a critical mediator of aberrant DNA damage response signaling in carboplatin-resistant ovarian cancer, indicating its potential as a druggable target for overcoming carboplatin resistance.

Schlagwörter

Stichwörter der Autor:innen

CarboplatinDNA repairMicropeptideOvarian cancerResistance

Autor:innen und Institutionen

  • Precision Medicine Institute, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, China.
  • Centre for Regenerative Medicine and Health, Hong Kong Institute of Science and Innovation, Chinese Academy of Sciences, Hong Kong, China.
  • Clinical Experimental Center, Jiangmen Key Laboratory of Clinical Biobanks and Translational Research, Jiangmen Central Hospital, Jiangmen, China.
  • Department of Biochemistry, Zhongshan School of Medicine, Guangzhou, China.
  • Department of Pathology, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, China.

ORCID-Profile: Ruyuan Yu

Zitieren

APA

Li, M., Xu, Y., Mai, Z., Ren, L., Yu, X., Chen, S., Ke, Z., & Yu, R. (2026). Long non-coding RNA LOC101926915-encoded micropeptide carboplatin-induced upregulation factor confers carboplatin resistance in ovarian cancer. Cytojournal, 23, 44. https://doi.org/10.25259/cytojournal_99_2025

Vancouver

Li M, Xu Y, Mai Z, Ren L, Yu X, Chen S, et al. Long non-coding RNA LOC101926915-encoded micropeptide carboplatin-induced upregulation factor confers carboplatin resistance in ovarian cancer. Cytojournal. 2026;23:44. doi:10.25259/cytojournal_99_2025

BibTeX
@article{Li2026,
  author = {Li, Man and Xu, YingRu and Mai, ZhiBiao and Ren, Liangliang and Yu, Xuexin and Chen, SuWen and Ke, ZunFu and Yu, Ruyuan},
  title = {Long non-coding RNA LOC101926915-encoded micropeptide carboplatin-induced upregulation factor confers carboplatin resistance in ovarian cancer},
  journal = {Cytojournal},
  year = {2026},
  volume = {23},
  pages = {44},
  doi = {10.25259/cytojournal_99_2025}
}
Kostenlos starten →